Target intelligence / Profile preview

Cystoisospora suis

Molecular classification
Other (apicomplexan parasite, coccidian)
01

Overview

Cystoisospora suis is an apicomplexan coccidian parasite that infects suckling piglets, causing neonatal porcine cystoisosporosis (also known as porcine coccidiosis), characterized by non-hemorrhagic diarrhea, mucosal damage in the small intestine, poor weight gain, and disrupted gut microbiome establishment. The parasite's direct life cycle occurs entirely within the pig host: sporulated oocysts are ingested, excyst, and release sporozoites that invade enterocytes, undergoing asexual merogony (multiple types peaking at 4-5 days post-infection) followed by sexual gamogony, leading to unsporulated oocysts excreted in feces that sporulate externally within days. Neonates are highly susceptible due to immature immune responses, while older pigs develop age-related resistance; extraintestinal stages in tissues like spleen, lymph nodes, and liver may enable persistence, though not fully confirmed. In disease, it destroys villous epithelium, promotes secondary bacterial invasions (e.g., E. coli), and results in high litter morbidity but low mortality. Toltrazuril is used for treatment, and genomic studies (~84 Mb, >8000 genes) suggest potential for new anticoccidials targeting kinases or parasite-specific pathways, given its relation to Toxoplasma and Neospora.

Other names
Isospora suis
02

Mechanism of action

null (no specific mechanisms detailed for drugs; toltrazuril treatment noted in infection studies)

03

Biological functions

Asexual reproduction (merogony)sexual reproduction (gametogony)invasion of intestinal epitheliumoocyst production and sporulation
04

Disease associations

Infection (neonatal porcine cystoisosporosis, porcine coccidiosis)
05

Interacting drugs

Toltrazuril

Beyond the preview

Go deeper on Cystoisospora suis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystoisospora suis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call